MJH Life Sciences™ Announces Acquisition of Cannabis Science Conference
MJH Life Sciences™ announces the acquisition of the Cannabis Science Conference, which hosts the world's largest and most technical scientific and medical cannabis events and is aimed at improving cannabis science and education.
MJH Life Sciences™ is excited to announce its acquisition of the Cannabis Science Conference (CSC Events, LLC), which organizes and hosts bi-annual scientific and medical cannabis events. CSC Events will continue to organize conferences that pull together cannabis industry experts, instrument manufacturers, testing laboratories, research scientists, medical practitioners, policymakers, and interested novices.
“We are thrilled to procure the Cannabis Science Conference as we continue to offer the latest education on testing methods, groundbreaking research, best practices, and patient stories that will hopefully continue to move the cannabis industry forward,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™.
As part of the acquisition, Josh Crossney, CEO and Founder of CSC Events, will continue his role with the conference as Director of Cannabis Events at MJH Life Sciences. CSC Events will join the cannabis portfolio at MJH Life Sciences™, which includes the Cannabis Science and Technology® and Cannabis Patient Care™ multimedia platforms.
“Over the years, we have successfully introduced world-leading cannabis experts, researchers, and medical practitioners and have educated thousands of attendees from all around the world. My team and I have worked tirelessly to reduce the stigma surrounding cannabis and to bridge the gaps between cannabis, science, and medicine,” said Josh Crossney. “I am very proud of the work Cannabis Science Conference has achieved globally and I am excited to join forces with MJH Life Sciences to take it to the next level. With the power of MJH, we will expand on our original mission of advancing cannabis science and reach an even broader audience.”
To learn more about the upcoming Cannabis Science Conference West in Long Beach, California May 18–20, 2022, please visit www.cannabisscienceconference.com/.
About MJH Life Sciences™
MJH Life Sciences™ is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.
About Cannabis Science Conference
Cannabis Science Conference (CSC Events, LLC) was founded in 2016 by Josh Crossney (President, CEO, and Founder) and hosts the world's largest and most technical scientific and medical cannabis events. CSC Events, LLC conferences pull together cannabis industry experts, instrument manufacturers, testing labs, research scientists, medical practitioners, policymakers and interested novices. The semi-annual events are aimed at improving cannabis science and education.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
